While expanded investment in cancer research has led to the development of new therapies and increased survival rates, the cost of cancer therapies continues to grow. United States medical expenditures for cancer in 2020 are projected to exceed $207 billion. Currently cancer care represents one of the highest cost medical diagnosis categories for most employers, and is typically the number one driver of large claims. There are both opportunities (changing science) and challenges (escalating cost, inconsistency in care) that employers need to be aware of.
Join us on July 17 for the first of our three-part series on Innovative Approaches to Cancer Care Delivery. Engage in a discussion on how cancer impacts employers and approaches that provide value across all points of cancer care.
The series will feature:
Webinar 1 (July 17): Why cancer matters to employers, importance of member experience and latest in evidence based care and risk mitigation approaches
Webinar 2 (August 21): Future of oncology care – Advances in cancer treatment that employers should understand
Webinar 3 (October 2): Oncology solutions across the care continuum and for all disease stages
Ron Fontanetta, Jeff Levin-Scherz, and Cara McNulty, Willis Towers Watson (July 17)